Entry Detail



General Information

Database ID:exR0231758
RNA Name:hsa-miR-133a-3p
RNA Type:miRNA
Chromosome:chr20
Starnd:+
Coordinate:
Start Site(bp):62564970End Site(bp):62564991
External Links:hsa-miR-133a-3p



Disease Information

Disease Name:Benign bone and soft tissue tumor
Disease Category:Other Diseases
MeSH ID:
Type:
Alias:



Expression Detail

GEO ID:GSE124158
Description:A serum miRNA classifier diagnoses bone and soft tissue sarcomas across various histological subtypes
Experimental Design:Cancer vs Control
Case Disease Type:Benign bone and soft tissue tumor
Case Disease SubType:NA
Case Sample:Benign bone and soft tissue tumor
Control Sample:Healthy
Number of Case:339
Number of Control:275
Number of Samples:614





Regulatory Relationship

mRNA targets:NA
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000591
chr15
41961025
41962156
+
hsa_circ_0001791
chr8
38879161
38880844
+
hsa_circ_0000712
chr16
68208276
68225678
+
hsa_circ_0001731
chr7
100731990
100738448
+
hsa_circ_0000241
chr10
70847874
70856944
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC016876.2
chr17
7581964
7584086
-
LINC02381
chr12
54126082
54147485
+
NEAT1
chr11
65422774
65445540
+
Display:



Experiment Detail

GEO ID:GSE124158
Sample Source:Blood
Source Fraction:Serum
Platform:GPL21263
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:2512
Sample treatment protocol:NA
RNA Extract protocol:Total RNA was extracted each from 300uL serum samples using 3D-Gene® RNA extraction reagent from liquid sample kit (Toray Industries, Inc.).
RNA library preparation protocol:miRNA was labeled using 3D-Gene® miRNA Labeling kit in accordance with the manufacturer's instructions.



Reference

PMID:30898996
Title:A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes
Author:Asano N, Matsuzaki J, Ichikawa M, Kawauchi J, Takizawa S, Aoki Y, Sakamoto H, Yoshida A, Kobayashi E, Tanzawa Y, Nakayama R, Morioka H, Matsumoto M, Nakamura M, Kondo T, Kato K, Tsuchiya N, Kawai A, Ochiya T
Journal:Nat Commun. 2019 Mar 21;10(1):1299.
Description:we investigated serum miRNA profiles from 1002 patientswith bone and soft tissue tumors representing more than 43 histological subtypes,including sarcomas, intermediate tumors, and benign tumors, to determine whether serum miRNA profiles could be used to specifically detect sarcomas.